Diligence memo · auto-generated · as of July 3, 2026

TrueNorth Lifesciences SPV-1 LLC

TrueNorth Lifesciences SPV-1 LLC has raised $548K over 1 round; too few niche peers to rank its valuation yet.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

TrueNorth Lifesciences SPV-1 LLC operates in Investment Vehicle, based in NEW YORK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

TrueNorth Lifesciences SPV-1 LLC has raised $548K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $548K on 2021-05-04.

Most recent recorded round closed around 2021-05-04.

Valuation (modeled)modeled

Provath models TrueNorth Lifesciences SPV-1 LLC at approximately $8.8M (range $365K–$77M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Not enough dated financing history to read a financing rhythm.

Comparablesmixed

Capital scale ranks ahead of 17% of Investment Vehicle peers (1793 compared).

Modeled value ranks above 27% of those peers.

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.